Multiple sclerosis is a disease where the immune system attacks the protective coating around nerve fibers in the brain and spinal cord

In multiple sclerosis (MS), your immune system mistakenly treats myelin—the fatty insulation that wraps around nerve fibers—as a threat and damages it. When myelin is damaged, nerve signals slow down or stop altogether. This disruption can affect movement, vision, balance, sensation, and cognition depending on where the damage occurs and how extensive it is.

The disease is unpredictable. Some people experience long periods with few or no symptoms, while others have symptoms that worsen steadily. The damage can accumulate over time, leading to permanent disability in some cases, though modern treatments have changed the outlook significantly for many people.

Key Takeaways

  • MS occurs when the immune system damages myelin, the protective coating around nerve fibers in the brain and spinal cord.
  • The disease has several patterns: relapsing-remitting (the most common), progressive, and secondary progressive, each with different symptom trajectories.
  • Common early symptoms include vision problems, fatigue, numbness, and weakness, though symptoms vary widely between individuals.
  • MS is diagnosed through a combination of MRI scans, spinal fluid tests, and neurological exams, not a single blood test.
  • The cause involves both genetic susceptibility and environmental triggers, meaning having a family history increases risk but does not may provide you will develop MS.

How the immune system causes nerve damage in MS

Normally, your immune system protects you by attacking bacteria, viruses, and other invaders. In MS, something goes wrong with this system. T cells and B cells—types of white blood cells—cross the blood-brain barrier and attack myelin as if it were a foreign threat. This triggers inflammation and causes the myelin sheath to break down.

When myelin is stripped away, the nerve fiber underneath (called an axon) becomes exposed and can be damaged. Early on, the body sometimes repairs some of this damage, which is why symptoms may improve on their own. Over time, however, the axons themselves can be permanently harmed, and the body's ability to repair them diminishes. This is why MS can lead to lasting disability if left untreated.

The four patterns of MS and what they mean

Relapsing-remitting MS (RRMS) is the most common form, affecting about 85 percent of people at diagnosis. In RRMS, you experience relapses (also called exacerbations or flare-ups) when new symptoms appear or existing ones worsen, followed by remissions when symptoms improve partially or completely. Relapses can last days to months, and remissions can last months to years.

Secondary progressive MS (SPMS) usually develops from RRMS after several years. During this phase, symptoms worsen more steadily over time, with or without relapses. The transition from relapsing-remitting to secondary progressive happens at different ages for different people.

Primary progressive MS (PPMS) accounts for about 10 to 15 percent of cases. In this pattern, symptoms worsen from the start without clear relapses and remissions. It tends to appear later in life and often affects the spinal cord more than the brain.

Progressive-relapsing MS (PRMS) is the rarest form. People have a steadily worsening disease course with occasional relapses on top of the overall progression.

Early symptoms and how they develop

MS symptoms depend on which parts of the brain and spinal cord are damaged. Common early signs include blurred or double vision, eye pain, numbness or tingling in the legs or face, weakness in the legs, fatigue that is not relieved by rest, and balance problems or dizziness. Some people also experience cognitive changes like difficulty concentrating or memory problems.

A first symptom is called a clinically isolated syndrome (CIS). Not everyone with a CIS will develop MS—about 60 percent of people with a CIS go on to have a second neurological event within several years, which would lead to an MS diagnosis. This is why doctors monitor people with a CIS over time rather than diagnosing MS immediately.

Symptoms can come and go unpredictably. Heat, stress, infection, and fatigue can temporarily worsen symptoms without causing new damage. This is called pseudorelapse and differs from a true relapse, where new inflammation is occurring.

What causes MS: genetics and environment

MS results from a combination of genetic and environmental factors. If a parent or sibling has MS, your risk is higher than the general population, but having a family history does not mean you will develop the disease. Identical twins have about a 30 percent concordance rate, meaning if one twin has MS, the other has roughly a 30 percent chance of developing it—not 100 percent.

Environmental triggers that researchers have identified include infection with Epstein-Barr virus (EBV), low vitamin D levels, smoking, and living farther from the equator. The farther north or south you live, the higher the MS rate, possibly because of less sun exposure and lower vitamin D production. None of these factors alone causes MS, but they may increase the risk in people who are genetically susceptible.

How MS is diagnosed

There is no single test for MS. Diagnosis relies on the McDonald Criteria, a set of guidelines that combine clinical symptoms, MRI findings, and laboratory results. An MRI of the brain and spinal cord shows lesions (areas of damage or inflammation). A lumbar puncture (spinal tap) analyzes cerebrospinal fluid for specific antibodies and proteins that suggest MS. A neurological exam tests reflexes, strength, vision, and coordination.

The diagnosis process can take weeks or months because doctors need to rule out other conditions that mimic MS, such as vitamin B12 deficiency, Lyme disease, or lupus. A second neurological event separated in time and space (occurring at different times and in different parts of the nervous system) strengthens the diagnosis, which is why doctors sometimes wait before confirming MS.

How MS differs from other neurological conditions

MS is sometimes confused with other conditions because symptoms overlap. Lupus and Lyme disease can cause similar neurological symptoms, but blood tests and imaging patterns differ. Amyotrophic lateral sclerosis (ALS) causes progressive weakness but does not produce the relapsing pattern or the specific MRI lesions seen in MS. Guillain-Barré syndrome causes rapid weakness but is a one-time event, not a chronic disease.

The key distinguishing feature of MS is the pattern of multiple lesions in the brain and spinal cord that appear at different times, combined with relapses and remissions (in most cases). This "dissemination in space and time" is central to the diagnosis.

Frequently Asked Questions

Is MS hereditary?

MS has a genetic component, but it is not purely hereditary. Having a parent or sibling with MS increases your risk, but most people with MS do not have a family history. Environmental factors also play a role, which is why genetics alone do not determine who develops the disease.

Can MS be cured?

Currently, there is no cure for MS. However, disease-modifying therapies can slow progression, reduce relapse frequency, and prevent new lesions from forming. Some people experience long periods with minimal symptoms, and early treatment has improved outcomes significantly.

Does MS always lead to disability?

MS affects people differently. Some have mild symptoms that do not progress much over decades, while others experience more significant disability. Modern treatments started early can reduce the risk of disability. The course is unpredictable, which is why regular monitoring and early intervention matter.

Can stress or weather trigger MS relapses?

Stress and heat can temporarily worsen existing symptoms without causing new inflammation—this is pseudorelapse. True relapses involve new inflammation visible on MRI. Infections are a more established trigger for relapses than weather or stress alone.

How common is MS?

MS affects roughly 2.3 million people worldwide. In North America and Europe, rates are higher than in other regions. Women are diagnosed about three times more often than men, though the reason for this difference is not fully understood.